Device-based Rate Versus Rhythm Control in Symptomatic Recent-onset Atrial Fibrillation (RACE 9 OBSERVE-AF)

NARecruitingINTERVENTIONAL
Enrollment

490

Participants

Timeline

Start Date

November 16, 2020

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2025

Conditions
Atrial Fibrillation
Interventions
OTHER

Rate control

Rate control drugs are administered to obtain symptom relief and a heart rate of \<110 bpm, followed by a 4-week telemonitoring period.

OTHER

Pharmacological or electrical cardioversion

Pharmacological or electrical cardioversion is performed to achieve restoration of sinus rhythm, either acutely or in a wait-and-see approach, all within 48 hours, and followed by a 4-week telemonitoring period.

Trial Locations (14)

6229AX

RECRUITING

Maastricht University Medical Center, Maastricht

1815JD

RECRUITING

Noordwest Ziekenhuisgroep, Alkmaar

Unknown

RECRUITING

Vrije Universiteit Medisch Centrum, Amsterdam

RECRUITING

Rijnstate, Arnhem

RECRUITING

Medisch Spectrum Twente, Enschede

RECRUITING

Martini Ziekenhuis, Groningen

RECRUITING

Universitair Medisch Centrum Groningen, Groningen

RECRUITING

Zuyderland Medisch Centrum, Heerlen

RECRUITING

Alrijne Ziekenhuis, Leiderdorp

RECRUITING

St Antonius Ziekenhuis, Nieuwegein

RECRUITING

Radboud UMC, Nijmegen

RECRUITING

Antonius Ziekenhuis, Sneek

RECRUITING

St. Elisabeth TweeSteden Ziekenhuis, Tilburg

RECRUITING

VieCuri Medical Centre, Venlo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

collaborator

Dutch Heart Foundation

OTHER

collaborator

Netherlands Organisation for Scientific Research

OTHER_GOV

lead

Maastricht University Medical Center

OTHER